Jill S. Lindberg

Medicine · Health Sciences

29h-index4.0kcitations71works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parathyroid Disorders and Treatments(18), Dialysis and Renal Disease Management(16), Kidney Stones and Urolithiasis Treatments(13), Pharmacological Effects and Toxicity Studies(13), Vitamin D Research Studies(9)

Publications71 total

The Feasibility and Efficacy of a Healthy Restaurant Initiative in Northwest Minnesota: Putting Health on the Menu Pilot Study
Journal of the Academy of Nutrition and Dietetics·2017
A Longitudinal Study of Uremic Pruritus in Hemodialysis Patients
Clinical Journal of the American Society of Nephrology·2010· 310 citedOpen Access
Real-World Doxercalciferol Treatment in SHPT CKD Stage 3 and 4: An Analysis of Change in iPTH and Accordance to KDOQI Recommendations
American Journal of Nephrology·2008· 2 cited
Calcimimetics: A new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic kidney disease
Kidney International·2005· 21 cited
Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis
Journal of the American Society of Nephrology·2005· 407 cited
Impact of multidisciplinary, early renal education on vascular access placement.
PubMed·2005· 24 cited
Carnitine Therapy Is Associated with Decreased Hospital Utilization among Hemodialysis Patients
American Journal of Nephrology·2005· 25 cited
Coronary and aortic calcifications in patients new to dialysis
Hemodialysis International·2004· 39 cited
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4
American Journal of Kidney Diseases·2004· 172 cited
Introduction
Seminars in Nephrology·2004· 4 cited
RENAL STONES: ANOTHER EXTRA HEPATIC MANIFESTATION OF HEPATITIS C?
The American Journal of Gastroenterology·2003
On the evolving nature of understanding dialysis-related disorders
American Journal of Kidney Diseases·2003· 100 cited
Practice recommendations for the use of L-Carnitine in dialysis-related carnitine disorder National Kidney Foundation Carnitine Consensus Conference
American Journal of Kidney Diseases·2003· 115 cited
Clinical management of dialysis-related carnitine deficiency: three case studies.
PubMed·2003· 2 cited
Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis
Kidney International·2003· 39 citedOpen Access
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism
Kidney International·2003· 235 cited
Treatment of Anemia with Darbepoetin Alfa Administered de novo Once Every Other Week in Chronic Kidney Disease
American Journal of Nephrology·2003· 56 citedOpen Access
Darbepoetin alfa: a new therapy for the management of anaemia associated with chronic kidney disease
Expert Opinion on Biological Therapy·2002· 8 cited
Hyperphosphatemia Management
Seminars in Dialysis·2002· 1 cited
Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients
American Journal of Kidney Diseases·2002· 213 cited
page 1 of 4Next →

Frequent Co-authors

Charles E. Wade(6), John B. Copley(6), Fred E. Husserl(5), Kévin Martin(4), Harold A. Fuselier(4), Dirk J. Kok(4), Francis E. Cole(4), Jack W. Coburn(3), E. A. González(3), Sharon M. Moe(3), Thomas H. Jurney(3), Howard M. Cushner(3), Donald T. Erwin(3), William R. J. Whitaker(3), L. Lee Hamm(2), H. E. Abboud(2), Michael J. Germain(2), Geoffrey A. Block(2), Stuart M. Sprague(2), Robert Brenner(2)